AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Pediatric Metabolic Dysfunction-associated Steatotic Liver Disease and Food Insecurity

Recruitingn/aAges 6 Years - 17 YearsAllUniversity of California, San Francisco
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This proposal addresses a critical gap in our understanding of the impact of household food insecurity (FI) on pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) severity. There is evidence that children in families that do not have the ability to provide consistently healthy and high-quality foods, such as fruits and vegetables, have worse diet quality that children in households that are food secure. Additionally, evidence from adult studies link household FI to MASLD and liver fibrosis, and prior research of the PI has shown that exposure to household FI in early childhood was associated with a nearly 4 times increased odds of pediatric MASLD in middle childhood. Possible mechanisms linking household FI to pediatric MASLD include lower intake of fruits and vegetables, higher intake of caloric dense nutrient poor foods (e.g., sugar sweetened beverages), and less

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Children and adolescents receiving care in the liver and WATCH clinics. * Family living in California. * Parent/guardian speaks Spanish or English. * Child is between the ages of 6 to \<17 years. * Elevated ALT on at least 2 occasions within the past year: * ALT \> 22 units/L for females. * ALT \> 26 units/L for males. * BMI for age/sex โ‰ฅ 85%. * Alternatively, child has one elevated ALT within the past year and confirmed steatosis on imaging. * Family does not intend to move out of California within the next year. * Family is not already receiving EatSF SF Fruit and Vegetable Vouchers. * Family is not participating in any other dietary education programs besides those offered by the WATCH or liver clinics. Exclusion Criteria: * Child has an underlying condition or medication causing their weight gain (e.g., hypothyroidism, Prader-Willi syndrome, antipsychotic medications). * Child is on, or expected to go on, or starts on a weight loss medication (e.g., Qsymia or GLP-1 receptor agonists). * Child has another known cause of liver disease (not including MASLD or MASH), such as: * Autoimmune hepatitis. * Wilson's disease. * Hepatitis A, B, or C. * Acute infection. * Genetic condition causing inflammation in the liver.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
University of California, San Francisco
San Francisco, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy